跳至主要内容
临床试验/NCT06668883
NCT06668883已完成不适用

Novel Exhaled Breath Aerosol Collection Devices in Patients With Lower Respiratory Tract Infection - a Performance and Acceptability Study (Acronym: AeroCAP)

Avelo AG1 个研究点 分布在 1 个国家目标入组 23 人开始时间: 2024年11月13日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
发起方
入组人数
23
试验地点
1
主要终点
Pathogen Concordance

研究概览

简要总结

This study will assess the performance of two novel breath collection devices and their subsequent detection of respiratory pathogens compared to sputum samples in patients with lower respiratory tract infections.

研究设计

研究类型
Observational
观察模型
Case Only
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Able to understand the scope of the study and provide written informed consent
  • Age >18 years
  • Speaking German or English
  • Health status (assessed by study personnel at local site) well enough to use the breath collection devices
  • Willing to provide all three study samples (sputum and two breath samples) required for the study
  • Clinical diagnosis of a lower respiratory tract infection (LRTI) defined as:
  • (i) New infiltrate (chest X-ray, ultrasound, or CT scan), and (ii) at least one clinical symptom suggestive of LRTI (fever ≥38°C, chills, new or worsening cough, new or worsening sputum production, new or worsening dyspnea, tachypnoea, chest pain)

排除标准

  • Patients for whom the collection of all three study specimens within 48 hours of initiating antibiotic treatment is not feasible
  • Patients with known cystic fibrosis or bronchiectasis
  • Critically ill patients at the discretion of the investigator
  • Patients on oxygen supplementation with a face mask, high-flow-oxygen, non-invasive or mechanical ventilation; oxygen supplementation via nasal cannula will be permitted.
  • Patients with proven acute pulmonary embolism
  • Patients with best supportive care
  • Patients with severe hypoxemia (SpO2 <88%) despite oxygen supplementation
  • Hospitalization within the last 14 days prior to admission

结局指标

主要结局

Pathogen Concordance

时间窗: 6 months

Overall percent agreement, negative percent agreement, and positive percent agreement between syndromic respiratory multiplex PCR results from breath samples and sputum samples.

次要结局

  • Usability(2 days after sample collection)
  • Expanded user feedback(2 days after sample collection)
  • Rates of indeterminate breath results(6 months)

研究者

发起方
Avelo AG
申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验